🇺🇸 FDA
Patent

US 6946132

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6946132 (Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis) held by The Regents of the University of California expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K39/00, A61K39/0008, A61K39/40